Literature DB >> 33450939

Recent Advances in Nanomedicine for the Diagnosis and Treatment of Prostate Cancer Bone Metastasis.

Daniel E Hagaman1, Jossana A Damasco1, Joy Vanessa D Perez1,2, Raniv D Rojo1,2, Marites P Melancon1,3.   

Abstract

Patients with advanced prostate cancer can develop painful and debilitating bone metastases. Currently available interventions for prostate cancer bone metastases, including chemotherapy, bisphosphonates, and radiopharmaceuticals, are only palliative. They can relieve pain, reduce complications (e.g., bone fractures), and improve quality of life, but they do not significantly improve survival times. Therefore, additional strategies to enhance the diagnosis and treatment of prostate cancer bone metastases are needed. Nanotechnology is a versatile platform that has been used to increase the specificity and therapeutic efficacy of various treatments for prostate cancer bone metastases. In this review, we summarize preclinical research that utilizes nanotechnology to develop novel diagnostic imaging tools, translational models, and therapies to combat prostate cancer bone metastases.

Entities:  

Keywords:  bone metastasis; nanomedicine; nanotechnology; prostate cancer

Year:  2021        PMID: 33450939      PMCID: PMC7828457          DOI: 10.3390/molecules26020384

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  217 in total

1.  Apparent diffusion coefficient and beyond: what diffusion MR imaging can tell us about tissue structure.

Authors:  Denis Le Bihan
Journal:  Radiology       Date:  2013-08       Impact factor: 11.105

Review 2.  Bisphosphonates: therapeutics potential and recent advances in drug delivery.

Authors:  Mohammad Fazil; Sanjula Baboota; Jasjeet K Sahni; Javed Ali
Journal:  Drug Deliv       Date:  2014-01-10       Impact factor: 6.419

Review 3.  Phenomenology of the Initial Burst Release of Drugs from PLGA Microparticles.

Authors:  Jin Yoo; You-Yeon Won
Journal:  ACS Biomater Sci Eng       Date:  2020-10-09

4.  Immunoelectron microscopy of osteonectin and type I collagen in osteoblasts and bone matrix.

Authors:  R Romanowski; G Jundt; J D Termine; K von der Mark; A Schulz
Journal:  Calcif Tissue Int       Date:  1990-06       Impact factor: 4.333

Review 5.  Matrix metalloproteinases as master regulators of the vicious cycle of bone metastasis.

Authors:  Conor C Lynch
Journal:  Bone       Date:  2010-06-16       Impact factor: 4.398

Review 6.  Macromolecule-drug conjugates in targeted cancer chemotherapy.

Authors:  H Sezaki; M Hashida
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1984       Impact factor: 4.889

7.  Vicrostatin - an anti-invasive multi-integrin targeting chimeric disintegrin with tumor anti-angiogenic and pro-apoptotic activities.

Authors:  Radu O Minea; Corey M Helchowski; Samuel J Zidovetzki; Fritz K Costa; Stephen D Swenson; Francis S Markland
Journal:  PLoS One       Date:  2010-06-03       Impact factor: 3.240

8.  Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival.

Authors:  Daniel A Hamstra; Craig J Galbán; Charles R Meyer; Timothy D Johnson; Pia C Sundgren; Christina Tsien; Theodore S Lawrence; Larry Junck; David J Ross; Alnawaz Rehemtulla; Brian D Ross; Thomas L Chenevert
Journal:  J Clin Oncol       Date:  2008-06-09       Impact factor: 44.544

9.  A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma.

Authors:  Fred Saad; Donald M Gleason; Robin Murray; Simon Tchekmedyian; Peter Venner; Louis Lacombe; Joseph L Chin; Jeferson J Vinholes; J Allen Goas; Bee Chen
Journal:  J Natl Cancer Inst       Date:  2002-10-02       Impact factor: 13.506

10.  The systemic delivery of an oncolytic adenovirus expressing decorin inhibits bone metastasis in a mouse model of human prostate cancer.

Authors:  W Xu; T Neill; Y Yang; Z Hu; E Cleveland; Y Wu; R Hutten; X Xiao; S R Stock; D Shevrin; K Kaul; C Brendler; R V Iozzo; P Seth
Journal:  Gene Ther       Date:  2014-12-11       Impact factor: 5.250

View more
  2 in total

Review 1.  Metal-based nano-delivery platform for treating bone disease and regeneration.

Authors:  Yanhua Liu; Zhengyi Xu; Mingxin Qiao; He Cai; Zhou Zhu
Journal:  Front Chem       Date:  2022-08-09       Impact factor: 5.545

Review 2.  Mediterranean Diet Food Components as Possible Adjuvant Therapies to Counteract Breast and Prostate Cancer Progression to Bone Metastasis.

Authors:  Paola Maroni; Paola Bendinelli; Alessandro Fulgenzi; Anita Ferraretto
Journal:  Biomolecules       Date:  2021-09-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.